EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 39 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,787,000 | +2.0% | 178,393 | +0.8% | 0.05% | +10.6% |
Q2 2022 | $1,752,000 | +80.6% | 176,993 | +79.9% | 0.05% | +88.0% |
Q1 2022 | $970,000 | +26.6% | 98,393 | +25.3% | 0.02% | +19.0% |
Q4 2021 | $766,000 | -0.3% | 78,498 | 0.0% | 0.02% | -8.7% |
Q3 2021 | $768,000 | – | 78,498 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 400,000 | $4,008,000 | 1.47% |
683 Capital Management, LLC | 600,000 | $6,012,000 | 0.46% |
CVI Holdings, LLC | 367,552 | $3,687,000 | 0.29% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $2,004,000 | 0.26% |
SkyView Investment Advisors, LLC | 71,773 | $719,000 | 0.21% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,999 | $10,020,000 | 0.20% |
GLAZER CAPITAL, LLC | 1,022,411 | $10,245,000 | 0.19% |
METEORA CAPITAL, LLC | 56,076 | $562,000 | 0.14% |
Cowen Investment Management LLC | 50,000 | $501,000 | 0.11% |
First Trust Capital Management L.P. | 208,598 | $2,090,000 | 0.10% |